Secondary Research

• Determined key drivers and barriers affecting stakeholder adoption of in-house NIPT testing based on lab type, hospital size, and rates of prenatal care
• Analyzed stakeholder feedback on three potential test profiles to determine strengths and weaknesses of test specifications, workflow, and technology
• Outlined customer profiles of stakeholders more likely to favor certain testing profiles and recommended tactics to drive adoption within these groups

‍Primary Research

• Assessed existing knowledge base of stakeholders regarding prenatal testing paradigms, including gaps in knowledge that limit current attractiveness of in-house testing
• Interviewees included lab personnel working across reference labs and hospital labs who conduct in-house women’s health molecular testing

‍